167 related articles for article (PubMed ID: 9681845)
1. The ultimate biochemical diagnosis of endocrine pancreatic tumours in MEN-1.
Oberg K; Skogseid B
J Intern Med; 1998 Jun; 243(6):471-6. PubMed ID: 9681845
[TBL] [Abstract][Full Text] [Related]
2. Prospective controlled trial of a standardized meal stimulation test in the detection of pancreaticoduodenal endocrine tumours in patients with multiple endocrine neoplasia type 1.
Langer P; Wild A; Celik I; Kopp I; Bergenfelz A; Bartsch DK
Br J Surg; 2001 Oct; 88(10):1403-7. PubMed ID: 11578300
[TBL] [Abstract][Full Text] [Related]
3. Prospective screening in multiple endocrine neoplasia type 1.
Skogseid B; Oberg K
Henry Ford Hosp Med J; 1992; 40(3-4):167-70. PubMed ID: 1362398
[TBL] [Abstract][Full Text] [Related]
4. Utility of chromogranin A, pancreatic polypeptide, glucagon and gastrin in the diagnosis and follow-up of pancreatic neuroendocrine tumours in multiple endocrine neoplasia type 1 patients.
Qiu W; Christakis I; Silva A; Bassett RL; Cao L; Meng QH; Gardner Grubbs E; Zhao H; Yao JC; Lee JE; Perrier ND
Clin Endocrinol (Oxf); 2016 Sep; 85(3):400-7. PubMed ID: 27256431
[TBL] [Abstract][Full Text] [Related]
5. Multiple endocrine neoplasia type 1 in patients with recognized pituitary tumours of different types.
Corbetta S; Pizzocaro A; Peracchi M; Beck-Peccoz P; Faglia G; Spada A
Clin Endocrinol (Oxf); 1997 Nov; 47(5):507-12. PubMed ID: 9425388
[TBL] [Abstract][Full Text] [Related]
6. Multiple endocrine neoplasia type 1: a 10-year prospective screening study in four kindreds.
Skogseid B; Eriksson B; Lundqvist G; Lörelius LE; Rastad J; Wide L; Akerström G; Oberg K
J Clin Endocrinol Metab; 1991 Aug; 73(2):281-7. PubMed ID: 1677362
[TBL] [Abstract][Full Text] [Related]
7. Islet amyloid polypeptide (IAPP) in patients with neuroendocrine tumours.
Stridsberg M; Eriksson B; Lundqvist G; Skogseid B; Wilander E; Oberg K
Regul Pept; 1995 Jan; 55(2):119-31. PubMed ID: 7754100
[TBL] [Abstract][Full Text] [Related]
8. Management of patients and subjects at risk for multiple endocrine neoplasia type 1: MEN 1. GENEM 1. Groupe d'Etude des Néoplasies Endocriniennes Multiples de type 1.
Chanson P; Cadiot G; Murat A
Horm Res; 1997; 47(4-6):211-20. PubMed ID: 9167954
[TBL] [Abstract][Full Text] [Related]
9. Gastrinomas associated with MEN-1 syndrome: new insights for the diagnosis and management in a series of 11 patients.
Nikou GC; Toubanakis C; Nikolaou P; Giannatou E; Marinou K; Safioleas M; Karamanolis D
Hepatogastroenterology; 2005; 52(66):1668-76. PubMed ID: 16334754
[TBL] [Abstract][Full Text] [Related]
10. Chromogranin a levels in diagnosis, treatment and follow-up of 42 patients with non-functioning pancreatic endocrine tumours.
Nikou GC; Marinou K; Thomakos P; Papageorgiou D; Sanzanidis V; Nikolaou P; Kosmidis C; Moulakakis A; Mallas E
Pancreatology; 2008; 8(4-5):510-9. PubMed ID: 18765956
[TBL] [Abstract][Full Text] [Related]
11. A standardized meal stimulation test of the endocrine pancreas for early detection of pancreatic endocrine tumors in multiple endocrine neoplasia type 1 syndrome: five years experience.
Skogseid B; Oberg K; Benson L; Lindgren PG; Lörelius LE; Lundquist G; Wide L; Wilander E
J Clin Endocrinol Metab; 1987 Jun; 64(6):1233-40. PubMed ID: 2883195
[TBL] [Abstract][Full Text] [Related]
12. A meal stimulation test in the diagnosis of pancreatic endocrine tumors in multiple endocrine neoplasia type 1.
Migliori M; Tomassetti P; Campana D; Boschi S; Pezzilli R; Piscitelli L; Corinaldesi R; Gullo L
Endocrine; 2002 Apr; 17(3):229-32. PubMed ID: 12108524
[TBL] [Abstract][Full Text] [Related]
13. Multiple endocrine neoplasia type 1.
Marini F; Falchetti A; Del Monte F; Carbonell Sala S; Gozzini A; Luzi E; Brandi ML
Orphanet J Rare Dis; 2006 Oct; 1():38. PubMed ID: 17014705
[TBL] [Abstract][Full Text] [Related]
14. Plasma chromogranin A in patients with multiple endocrine neoplasia type 1.
Granberg D; Stridsberg M; Seensalu R; Eriksson B; Lundqvist G; Oberg K; Skogseid B
J Clin Endocrinol Metab; 1999 Aug; 84(8):2712-7. PubMed ID: 10443665
[TBL] [Abstract][Full Text] [Related]
15. Plasma chromogranin A in patients with sporadic gastro-entero-pancreatic neuroendocrine tumors or multiple endocrine neoplasia type 1.
Peracchi M; Conte D; Gebbia C; Penati C; Pizzinelli S; Arosio M; Corbetta S; Spada A
Eur J Endocrinol; 2003 Jan; 148(1):39-43. PubMed ID: 12534356
[TBL] [Abstract][Full Text] [Related]
16. Meal-stimulated and atropine-inhibited secretion of pancreatic polypeptide in healthy subjects, members of MEA I families and patients with malignant endocrine tumours of the gastrointestinal tract.
Oberg K; Lundqvist G
Regul Pept; 1983 Feb; 5(3):273-82. PubMed ID: 6133318
[TBL] [Abstract][Full Text] [Related]
17. Multiple endocrine neoplasia type 1 (MEN-1). Clinical, biochemical and genetical investigations.
Oberg K; Skogseid B; Eriksson B
Acta Oncol; 1989; 28(3):383-7. PubMed ID: 2568120
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone overproduction in a patient with multiple endocrine neoplasia type I.
Hermans MM; Lips CJ; Bravenboer B
J Intern Med; 2000 Dec; 248(6):525-30. PubMed ID: 11155146
[TBL] [Abstract][Full Text] [Related]
19. Genetic, clinical, and biochemical analysis of unrelated Spanish families with multiple endocrine neoplasia type I.
Chico A; Gallart L; Martín-Campos JM; Catasús L; Mayoral C; Mato E; Tortosa F; Bernà L; Rodríguez-Espinosa J; Blanco-Vaca F; Matías-Guiu X; de Leiva A; Mauricio D
Endocr Pract; 2000; 6(1):13-9. PubMed ID: 11419921
[TBL] [Abstract][Full Text] [Related]
20. Prospective endoscopic ultrasonographic evaluation of the frequency of nonfunctioning pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1.
Thomas-Marques L; Murat A; Delemer B; Penfornis A; Cardot-Bauters C; Baudin E; Niccoli-Sire P; Levoir D; Choplin Hdu B; Chabre O; Jovenin N; Cadiot G;
Am J Gastroenterol; 2006 Feb; 101(2):266-73. PubMed ID: 16454829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
